Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Videos
Diagnostics
In Vitro Diagnostics
Return to: MDBR Home | Diagnostics | In Vitro Diagnostics | News
Search Refinements

In Vitro Diagnostics News

View news from other Medical Devices sectors:
91-105 of 2959 results
Interpace Diagnostics announces $4.2m registered direct offering of common stock
Interpace Diagnostics Group, a company that provides clinically useful molecular diagnostic tests and pathology services, announced that it has entered into a securities purchase agreement with certain institutional investors.
Diagnostics > In Vitro Diagnostics > News
VolitionRx’s new cancer diagnostic test wins CE mark approval
By MDBR Staff Writer
VolitionRx has received CE mark approval for its Nu.Q colorectal cancer screening triage test to market in the European countries.
Diagnostics > In Vitro Diagnostics > News
Zymo Research introduces new sample collection devices with DNA/RNA reagent
US-based company Zymo Research has introduced five new sample collection devices that contain DNA/RNA Shield storage reagent.
Diagnostics > In Vitro Diagnostics > News
Roche launches CT/NG on cobas 6800/8800 systems
Roche has launched CT/NG on the cobas 6800/8800 Systems in markets accepting the CE mark.
Diagnostics > In Vitro Diagnostics > News
Biocartis submits 510(k) file with US FDA for Idylla platform
Biocartis Group has announced the 510(k) submission to the US Food and Drug Administration (FDA) of its rapid, fully automated molecular diagnostics platform Idylla(TM), consisting of the Idylla(TM) Instrument and the Idylla Console.
Diagnostics > In Vitro Diagnostics > News
United Rheumatology recommends Vectra DA test for adults with rheumatoid arthritis
Crescendo Bioscience, a wholly-owned subsidiary of Myriad Genetics, announced that United Rheumatology, a leading professional organization for rheumatologists in the United States with more that 300 members, has added Vectra DA to its clinical practice guidelines for adults with rheumatoid arthritis (RA).
Diagnostics > In Vitro Diagnostics > News
Akers Biosciences signs three-year agreement with GNYHA Services for heparin PF4 rapid test
Akers Biosciences, a developer of rapid health information technologies, reported that it has signed a three-year agreement with the Greater New York Hospital Association (GNYHA) to introduce the company's flagship rapid tests for heparin-induced thrombocytopenia across GNYHA's network of over 300 member hospitals and health systems.
Diagnostics > In Vitro Diagnostics > News
GenMark seeks FDA approval for ePlex respiratory pathogen panel
By MDBR Staff Writer
GenMark Diagnostics is seeking approval from the US Food and Drug Administration (FDA) for its ePlex sample-to-answer instrument and respiratory pathogen panel.
Diagnostics > In Vitro Diagnostics > News
Exosome Diagnostics presents highest sensitivity liquid biopsy test for lung cancer
Exosome Diagnostics has presented data that sets a new standard for EGFR-T790M resistance mutation detection in lung cancer, with the highest sensitivity reported to date.
Diagnostics > In Vitro Diagnostics > News
Agilent, Rubicon sign supply agreement for PicoPLEX WGA kits
By MDBR Staff Writer
Rubicon Genomics has entered into a supply agreement with Agilent Technologies for its PicoPLEX WGA kits.
Diagnostics > In Vitro Diagnostics > News
Invitae expands pediatric, neurological, and rare disease genetic test offerings
By MDBR Staff Writer
US genetic information firm Invitae has expanded its pediatric, neurological, and rare disease genetic test offerings with new and extended panels.
Diagnostics > In Vitro Diagnostics > News
Bayer, Leica Biosystems to develop companion diagnostic tests for cancer patients
Bayer has entered into an agreement with Leica Biosystems to collaborate on the development of companion diagnostic tests based on tissue samples using RNAscope (a multiplex nucleic acid hybridization technology) and immunohistochemistry for cancer patients.
Diagnostics > In Vitro Diagnostics > News
Personal Genome Diagnostics launches CancerSELECT 125 test for pan-cancer tumor profiling
Personal Genome Diagnostics (PGDx), a provider of advanced cancer genome testing products and services, today announced the launch of its CancerSELECT 125 test for pan-cancer tumor profiling.
Diagnostics > In Vitro Diagnostics > News
Foundation Medicine receives FDA approval of FoundationFocus CDxBRCA as companion diagnostic for Rubraca
By MDBR Staff Writer
Foundation Medicine (FMI) announced that the US Food and Drug Administration (FDA) has approved FoundationFocus CDxBRCA for use as a companion diagnostic to aid in identifying women with ovarian cancer for whom treatment with Rubraca™ (rucaparib), a therapy developed by Clovis Oncology, is being considered.
Diagnostics > In Vitro Diagnostics > News
Clinical Genomics launches blood-based test for CRC recurrence monitoring
By MDBR Staff Writer
Clinical Genomics has introduced a new a blood-based test for colorectal cancer (CRC) recurrence monitoring.
Diagnostics > In Vitro Diagnostics > News
91-105 of 2959 results